Table 5.
Overall summary of results of different patient-related outcomes for chronic tendinopathy (table 5A and B) and acute tendinopathy (table 5C) separately
| (A) | |||||||||||||
| Tendon affected | Author | Pain (unspecified) | Pain at rest | Pain at night | Pain with activity | Tenderness | ROM | Force | Satisfaction | Asymptomatic with ADLs | Function | Headache | Rash |
| Patellar | Steunebrink et al 35 | – | – | – | ↔ | – | – | – | – | – | – | ↔ | ↑ |
| Overall patellar (evidence level) | – (4) | – (4) | – (4) | ↔ (3) | – (4) | – (4) | – (4) | – (4) | – (4) | – (4) | – | – | |
| Rotator cuff | Giner-Pascual et al 33 | – | – | -– | – | – | – | – | – | – | – | ↑ | ↔ |
| Paoloni et al 29 | – | ↔ | ↔ | ↔ | ↔ | ↔ | ↑ | – | – | – | ↑ | ↑ | |
| Overall rotator cuff (evidence level) | – (4) | ↔ (3) | ↔ (3) | ↔ (3) | ↔ (3) | ↔ (3) | ↑ (3) | – (4) | – (4) | – (4) | – | – | |
| Achilles | Kane et al 30 | – | – | – | – | – | – | – | – | – | – | ↑ | ↔ |
| Paoloni et al 28 | – | ↔ | ↔ | ↔ | ↔ | – | ↔ | – | – | – | ↔ | ↔ | |
| Overall Achilles (evidence level) | – (4) | ↔ (3) | ↔ (3) | ↔ (3) | ↔ (3) | -– (4) | ↔ (3) | – (4) | – (4) | – (4) | – | – | |
| Wrist extensors | Ozden et al 34 | ↓ | – | – | – | – | – | ↔ | – | – | – | ↑ | ↔ |
| Paoloni et al 31 | – | ↔ | – | ↓ | – | – | ↔ | ↔ (SGAC) | – | ↔ (PRTEV) | ↑ | ↔ | |
| Paoloni et al 27 | – | ↔ | ↔ | ↓ | ↓ | – | ↔ | – | – | – | ↔ | ↑ | |
| Overall wrist extensors (evidence level) | ↓ (3) | ↔42 | ↔ (3) | ↓42 | ↓ (3) | - (4) | ↔42 | ↔ (3) | – (4) | ↔ (3) | – | – | |
| Overall all tendinopathies (evidence) | ↓ (3) | ↔42 | ↔42 | ↔ (3) | ↔ (3) | ↔ (3) | ↔42 | ↔ (3) | – (4) | ↔ (3) | ↑42 | ↔ (3) | |
| Tendon affected | Author | Pain (unspecified) | Pain at rest | Pain at night | Pain with activity | Tenderness | ROM | Force | Satisfaction | Asymptomatic with ADLs | Function | Headache | Rash |
| (B) | |||||||||||||
| Patellar | Steunebrink et al 35 | – | – | – | ↔ | – | – | – | ↔ | – | ↔ (VISA-P) | ↔ | ↑ |
| Overall patellar (evidence level) | – (4) | – (4) | – (4) | ↔ (3) | – (4) | – (4) | – (4) | ↔ (3) | – (4) | ↔ (3) | – | – | |
| Rotator cuff | Giner-Pascual et al 33 | ↓ | – | – | – | – | ↑ | – | – | – | – | ↑ | ↔ |
| Paoloni et al 29 | – | ↔ | ↓ | ↓ | ↔ | ↑ | ↑ | ↑ | ↑ | – | ↑ | ↑ | |
| Overall rotator cuff (evidence level) | ↓ (3) | ↔ (3) | ↓ (3) | ↓ (3) | ↔ (3) | ↑42 | ↑ (3) | ↑ (3) | ↑ (3) | – (4) | – | – | |
| Achilles | Kane et al 30 | ↔ | – | – | – | – | – | – | – | – | – | ↑ | ↔ |
| Paoloni et al 28 | - | ↔ | ↓ | ↓ | ↓ | – | ↑ | ↑ | ↑ | – | ↔ | ↔ | |
| Overall achilles (evidence level) | ↔ (3) | ↔ (3) | ↓ (3) | ↓ (3) | ↓ (3) | - (4) | ↑ (3) | ↑ (3) | ↑ (3) | - (4) | |||
| Wrist extensors | Ozden et al 34 | ↓ | – | – | – | – | – | ↔ | ↑ | – | – | ↑ | ↔ |
| Paoloni et al 31 | – | – | – | – | – | – | – | – | – | – | ↑ | ↔ | |
| Paoloni et al 27 | - | ↔ | ↔ | ↔ | ↓ | – | ↑ | ↑ | ↑ | – | ↔ | ↑ | |
| Overall wrist extensor (evidence level) | ↓ (3) | ↔ (3) | ↔ (3) | ↔ (3) | ↓ (3) | - (4) | ↑ (3) | ↑42 | ↑ (3) | – (4) | |||
| Overall all tendinopathies (evidence level) | ↓42 | ↔42 | ↓ (3) | ↓ (3) | ↓ (3) | ↑42 | ↑42 | ↑42 | ↑42 | ↔ (3) | ↑42 | ↔ (3) | |
| (C) | |||||||||||||
| Tendon affected | Author | Pain (unspecified) | Pain at rest | Pain duration | ROM | Hours of sleep | Satisfaction | Headache | Rash | ||||
| Rotator cuff | Berrazueta et al 13 | ↓ | – | ↓ | ↑ | ↑ | ↑ | ↑ | ↔ | ||||
| Pons et al 32 | – | ↑ | – | – | – | – | ↑ | ↔ | |||||
| Overall rotator cuff (evidence level) | ↓ (3) | ↑ (3) | ↓ (3) | ↑ (3) | ↑ (3) | ↑ (3) | ↑ (3) | ↔ (3) | |||||
Short-term (0–8 weeks) and midterm (12–24 weeks) outcomes of chronic tendinopathy are presented separately in table 5A and B, respectively. Level of evidence is provided in brackets for each overall outcome separately.
ADLs, activities of daily living; ROM, range of movement.